Pfizer sells bigger-than-expected stake in Haleon
![Haleon | Sharecast graphic / Josh White dl haleon consumer goods products personal care gsk ftse 100 logo](https://img.s3wfg.com/web/img/images_uploaded/9/3/dl-haleon-consumer-goods-products-personal-care-gsk-ftse-100-logo_620x350.jpg)
Haleon
353.00p
16:34 26/07/24
1.35%
4.70p
Haleon said on Tuesday that Pfizer has sold a larger-than-expected stake in the consumer healthcare group, taking its interest down to 22.6% from 32%.
FTSE 100
8,285.71
16:45 26/07/24
n/a
n/a
FTSE 350
4,586.28
16:45 26/07/24
n/a
n/a
FTSE All-Share
4,544.36
16:29 26/07/24
n/a
n/a
Pfizer Inc.
$30.77
11:09 26/07/24
1.95%
$0.59
Pharmaceuticals & Biotechnology
22,767.31
16:45 26/07/24
1.27%
284.71
Pfizer was planning to sell around 630m shares in a public offering but the size of the offering was increased to just over 790.5m.
Haleon sold 594m ordinary shares at £3.08 each and 196.5m American Depository Shares (ADR) at $7.85 each. It raised around £1.8bn and $1.5bn, respectively.
The maker of Sensodyne toothpaste and Panadol said it has also agreed to buy back 102.2m ordinary shares from Pfizer off-market for around £315m.